Kylie Mason

Associate Professor Kylie Mason

MBBS FRACP FRCPA PhD Chair VCCC Cancer Education and Training Advisory Committee
Alliance position: Consultant Haematologist and Clinician Researcher, Peter MacCallum Cancer Centre, The Royal Melbourne Hospital; Clinical Associate Professor, Sir Peter MacCallum Department of Oncology, University of Melbourne, Senior Research Fellow University of Sydney View alliance profile

The VCCC aims to provide collaborative learning and development opportunities for future leaders and practitioners in cancer research, education and clinical care. Education and training for the cancer workforce is highlighted as a major component of the Strategic Research Plan 2017-2020. A host of flexible education programs is now available – and continue to be developed for the cancer workforce to accelerate improved patient outcomes.

As Chair VCCC Cancer Education and Training Advisory Committee (CETAC), Associate Professor Kylie Mason provides leadership to the Education and Training portfolio, harnessing the collective knowledge of the VCCC alliance and its broader networks.

Working closely with Michelle Barrett, Head, Education and Training Development and her team, Associate Professor Mason provides leadership and strategic direction for the CETAC and the education and training that it governs.

The primary aim of her role is to oversee and develop an education and training program which will contribute to the establishment of a highly trained clinical, research and education workforce to meet the increasingly complex demands of their roles.

Associate Professor Mason is a dual trained academic haematologist (FRACP/FRCPA) with a clinical appointment in the Haematology Unit at the Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, a clinical associate professor with the Sir Peter MacCallum Department of Oncology, the University of Melbourne and Senior Research Fellow at the University of Sydney.

She also completed a basic science PhD in cancer medicine at the Walter and Eliza Hall Institute focusing on new drugs for leukaemia and lymphoma and the biology of platelets. In addition, she is actively involved in teaching medical students, basic and advanced physician trainees and nursing/allied health staff and is subject coordinator for the basic haematology module of the post graduate Masters of Internal Medicine degree for the University of Melbourne and the University of Sydney.

She has an interest in Adolescent and Young Adult (AYA) Haematology. Associate Professor Mason has a research interest in lymphoma and CLL and is the lead investigator for a number of clinical trials. Associate Professor Mason is a member of the national Pharmaceutic Benefits Advisory Committee and the Cancer Council Victoria Standing Research Subcommittee.